Navigation Links
Drug-Coated Stent

A new study shows drug-emitting stents are effective at keeping arteries open in even the most complex of patients. Researchers looked at stents coated with the drug sirolimus. It is an immunosuppressive agent. The goal when used in heart patients is to prevent the artery from closing again.//

Stents are used to prop open an artery and doctors say they have been very useful. However, in 30 percent of patients with diabetes, small coronary blood vessels, and long lesions, the area that was treated closes up again. For the last 20 years, doctors have been working to devise medications to prevent the problem from recurring. This new study looked at a drug-coated stent in patients with more challenging cardiac problems.

The study, included 53 medical centers in the United States. More than 1,000 patients received either a sirolimus-coated stent or a standard stent. The researchers report the rate of the artery re-closing with the use of the sirolimus stent was reduced from 21 percent to 8.5 percent.

Researchers say, "In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect." Both future blockages and other medical problems were avoided. Investigators suggest the results show both improved effectiveness and safety and perhaps they will alter the future of coronary treatments.
'"/>




Page: 1

Related medicine news :

1. Failure of Drug-Coated Stent
2. Stronger Backing for Drug-Coated Stents
3. Drug-Coated Stents – Proven to be More Effectiv
4. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
5. Stent shows promise in keeping arteries open
6. Failure of Drug-Coated Stent
7. Stronger Backing for Drug-Coated Stents
8. Drug-Coated Stents – Proven to be More Effectiv
9. Stent Effective In Keeping Arteries Open
10. The Efficacy Of Newer Stents Questioned
11. Analyzing The Side Effects Of Sirolimus Stents
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... R.I. (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much more ... Foundation (NSF), going just 19 hours without sleep can compromise motor reaction time, which can ... Week, and Amica Insurance is sharing the following tips from the NSF to help you ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... People are ... older people. “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa ... Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec ... Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to their ... expert that specializes in long-term care, Brooke Grove now has the capability to ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Christie ... today announced an alliance with B. Braun Medical Inc. , a leader in ... in patient care with as many as 90 percent of hospital patients receiving a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... Research and Markets has announced the addition of the "Global ... and Increasing Usage of Complex Biologics during the Forecast Period" ... The ... Billion in 2015 to around USD 26 Billion by 2020. ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: